Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations
Description
CONCLUSIONS: When combined dexamethasone and LTIs provided a mortality benefit in COVID-19 patients presenting with an O(2) saturations <50%. The LTI cohort had lower markers of inflammation and cytokine storm.
